TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Popular Reads
No popular reads data found
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search results
Popular Reads
No popular reads data found
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search resultsAstraZeneca
Society 1 year ago
PREMIUM
Ministry urges calm following COVID-19 vaccine’s side effect admission
In a recent legal defense against a class action lawsuit, British-Swedish pharmaceutical firm AstraZeneca admitted that its vaccine can "in very rare cases, cause TTS", while acknowledging that the causal mechanism was yet known.
Society 4 years ago
Indonesia extends AstraZeneca vaccine shelf life as 6 million doses near expiry
The decision underscores challenges many developing countries face in their slow inoculation campaigns, as vaccines donated by wealthy countries arrive with a relatively short shelf life of just a few months or even weeks.
Europe 4 years ago
PREMIUM
New COVID-19 drug promises better prevention, treatment: AstraZeneca
Phase-three clinical trials conducted by AstraZeneca suggest that a single dose of the antibody combination AZD7442 (commercially called Evusheld) is 83 percent effective at preventing severe COVID-19 in people over the age of 18 and could offer protection more than six months after administration.
Health 4 years ago
AstraZeneca's antibody therapy prevents COVID-19, study shows
The company said on Friday that 75 percent of the participants in the trial for the therapy - two types of antibodies discovered by Vanderbilt University Medical Center - had chronic conditions including some with a lower immune response to vaccinations.
